Ronald Hunt M.'s most recent trade in Rallybio Corp was a trade of 28,500 Option (Right to Buy) done . Disclosure was reported to the exchange on May 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rallybio Corp | Ronald M. Hunt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 28,500 | 28,500 | - | - | Option (Right to Buy) | |
| Rallybio Corp | Ronald M. Hunt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 73,571 | 73,571 | - | - | Option (Right to Buy) | |
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 06 Aug 2024 | 364,906 | 0 | - | - | Subscription Rights (right to buy) | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 06 Aug 2024 | 182,453 | 253,898 (1%) | 1% | - | Ordinary Shares | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 06 Aug 2024 | 182,453 | 182,453 | - | - | Warrants (right to buy) | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 06 Aug 2024 | 182,453 | 182,453 | - | - | Warrants (right to buy) | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 06 Aug 2024 | 130,962 | 0 | - | - | Subscription Rights (right to buy) | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 06 Aug 2024 | 65,481 | 65,481 | - | - | Warrants (right to buy) | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 06 Aug 2024 | 65,481 | 91,122 (0%) | 0% | - | Ordinary Shares | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 06 Aug 2024 | 65,481 | 65,481 | - | - | Warrants (right to buy) | ||
| Rallybio Corp | Ronald M. Hunt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 16,500 | 16,500 | - | - | Option (Right to Buy) | |
| Rallybio Corp | Ronald Hunt M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 29,096 | 29,096 | - | - | Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Ronald M. Hunt | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 1,072 | 12,801 (0%) | 0% | 0 | Common Stock | |
| Harpoon Therapeutics Inc | Ronald M. Hunt | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 18,656 | 36,941 (0%) | 0% | 0 | Common Stock | |
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 01 Jul 2023 | 2,796 | 8,867 (0%) | 0% | - | Ordinary Shares | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 01 Jul 2023 | 2,796 | 0 | - | - | Restricted Share Units | ||
| Harpoon Therapeutics Inc | Ronald M. Hunt | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 23,000 | 23,000 | - | - | Director Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Ronald M. Hunt | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 18,285 | 18,285 (0%) | 0% | 0 | Common Stock | |
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 01 Apr 2023 | 2,041 | 0 | - | - | Restricted Share Units | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 01 Apr 2023 | 2,041 | 6,071 (0%) | 0% | 0 | Ordinary Shares | ||
| Harpoon Therapeutics Inc | Ronald M. Hunt | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Mar 2023 | 2,994,305 | 2,994,305 | - | - | Common Stock Warrant (Right to Buy) | |
| Harpoon Therapeutics Inc | Ronald M. Hunt | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1000.00 per share. | 23 Mar 2023 | 10,000 | 10,000 | - | 1000 | 10,000,000 | 8.000% Series A Redeemable Preferred Stock |
| Rallybio Corp | Ronald M. Hunt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 11,099 | 11,099 | - | - | Option (Right to Buy) | |
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 01 Jan 2023 | 1,197 | 0 | - | - | Restricted Share Units | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 01 Jan 2023 | 1,197 | 4,030 (0%) | 0% | - | Ordinary Shares | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 23 Dec 2022 | 5,479 | 5,479 | - | - | Restricted Share Units | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 25 Sep 2022 | 2,796 | 2,796 | - | - | Restricted Share Units | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 25 Jun 2022 | 30,623 | 30,623 | - | - | Restricted Share Units | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 23 Jun 2022 | 36,798 | 42,501 (0%) | 0% | - | Ordinary Shares | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 23 Jun 2022 | 36,798 | 0 | - | - | Restricted Share Units | ||
| Harpoon Therapeutics Inc | Ronald M. Hunt | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 32,142 | 32,142 | - | - | Director Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Ronald M. Hunt | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 10,167 | 10,167 | - | - | Director Stock Option (Right to Buy) | |
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 15 Jun 2022 | 647,059 | 647,059 | - | - | Share Option (Right to Buy) | ||
| Rallybio Corp | Ronald M. Hunt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 13,440 | 13,440 | - | - | Option (Right to Buy) | |
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 25 Mar 2022 | 17,955 | 17,955 | - | - | Restricted Share Units | ||
| Rallybio Corp | Ronald M. Hunt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 6,242 | 6,242 | - | - | Option (Right to Buy) | |
| Rallybio Corp | Ronald M. Hunt | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 8,742,654 | 0 | - | - | Series A-2 Preferred Units | |
| Rallybio Corp | Ronald M. Hunt | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 2,157,838 | 0 | - | - | Series B Preferred Units | |
| Rallybio Corp | Ronald M. Hunt | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 1,993,911 | 1,993,911 | - | - | Common Stock | |
| Rallybio Corp | Ronald M. Hunt | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 1,795,946 | 0 | - | - | Series A-1 Preferred Units | |
| Rallybio Corp | Ronald M. Hunt | Director | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 28 Jul 2021 | 153,846 | 2,301,603 | - | 13 | 1,999,998 | Common Stock |
| Rallybio Corp | Ronald M. Hunt | Director | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 28 Jul 2021 | 153,846 | 2,147,757 | - | 13 | 1,999,998 | Common Stock |
| Rallybio Corp | Ronald M. Hunt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 13,440 | 13,440 | - | - | Option (Right to Buy) | |
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 23 Jun 2021 | 36,798 | 36,798 | - | - | Restricted Stock Units | ||
| Harpoon Therapeutics Inc | Ronald M. Hunt | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 11 Jan 2021 | 235,294 | 913,860 (3%) | 0% | 17 | 3,999,998 | Common Stock |
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 01 Jul 2020 | 5,703 | 0 | - | - | Restricted Stock Units | ||
| Iterum Therapeutics Plc | Ronald M. Hunt | Director | 01 Jul 2020 | 5,703 | 5,703 (0%) | 0% | - | Ordinary Shares |